MENU
ARGX
AS OF
Nov 13 closing price
Price
$891.73
Change
+$1.84 (+0.21%)
Capitalization
55.52B
104 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
ARGX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

argenx SE (ARGX) Earnings Date & Reports

Argenx is a Dutch biopharmaceutical company focused on developing antibody-based therapies for rare autoimmune diseases... Show more

A.I. Advisor
published Earnings

ARGX is expected to report earnings to rise 17.57% to $6.09 per share on February 26

argenx SE ARGX Stock Earnings Reports
Q4'25
Est.
$6.09
Q3'25
Beat
by $0.74
Q2'25
Beat
by $3.26
Q1'25
Beat
by $0.34
Q4'24
Beat
by $10.57
The last earnings report on October 30 showed earnings per share of $5.18, beating the estimate of $4.44. With 321.15K shares outstanding, the current market capitalization sits at 55.52B.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
ARGX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ARGX showed earnings on October 30, 2025. You can read more about the earnings report here.
View AI-Driven Trading for ARGX
A.I. Advisor
published General Information

General Information

a manufacturer of antibody-based medicines

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
Laarderhoogtweg 25
Phone
+31 107038441
Employees
1148
Web
https://www.argenx.com